Please assess the completion status of the following clinical trial:

Trial Title: Study of the Efficacy of Percutaneous Implantation of Autologous Myoblasts in Patients With Old Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with diagnosis of myocardial infarction, absence of viability.~* Ejection fraction under 40% or 45% in symptomatic patients~* Aged from 30-80 years old.~* Negative pregnancy test (women of childbearing age)~* Informed consent granted~Exclusion Criteria:~* Prior history of tachycardia or ventricular fibrillation (except in the acute phase of MI).~* Myocardial infarction with more than 10 years of evolution.~* Patients positive for HIV, HBV or HCB.~* Patients with organ dysfunction: liver and kidney function~* History of cancer or prior treatment with chemotherapy.~* The patient should not suffer from any concomitant severe and/or uncontrolled medical condition.~* Patients who, due to their geographical, psychiatric or social status, have difficulties in meeting the conditions established in the protocol.~* Pregnant or beast feeding women.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Skeletal myoblasts (Type: EXPERIMENTAL): Percutaneous autologous myoblast implantation
- No cells (Type: PLACEBO_COMPARATOR): Percutaneous culture medium without cells implantation

Based on this trial design, predict the completion outcome and termination type (if applicable).